AU4307997A - Nucleic acid particle delivery - Google Patents

Nucleic acid particle delivery

Info

Publication number
AU4307997A
AU4307997A AU43079/97A AU4307997A AU4307997A AU 4307997 A AU4307997 A AU 4307997A AU 43079/97 A AU43079/97 A AU 43079/97A AU 4307997 A AU4307997 A AU 4307997A AU 4307997 A AU4307997 A AU 4307997A
Authority
AU
Australia
Prior art keywords
nucleic acid
particle delivery
acid particle
delivery
nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43079/97A
Other languages
English (en)
Inventor
Terry Lee Burkoth
Andrew Gordon Muddle
Linda Maree Porter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Powderject Research Ltd
Original Assignee
Powderject Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Research Ltd filed Critical Powderject Research Ltd
Publication of AU4307997A publication Critical patent/AU4307997A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/89Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU43079/97A 1996-09-11 1997-09-11 Nucleic acid particle delivery Abandoned AU4307997A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9619002.0A GB9619002D0 (en) 1996-09-11 1996-09-11 Particle delivery
GB9619002 1996-09-11
PCT/GB1997/002478 WO1998010750A2 (en) 1996-09-11 1997-09-11 Nucleic acid particle delivery

Publications (1)

Publication Number Publication Date
AU4307997A true AU4307997A (en) 1998-04-02

Family

ID=10799793

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43079/97A Abandoned AU4307997A (en) 1996-09-11 1997-09-11 Nucleic acid particle delivery

Country Status (7)

Country Link
EP (1) EP0928190B1 (enExample)
JP (1) JP2001500858A (enExample)
AU (1) AU4307997A (enExample)
DE (1) DE69731646T2 (enExample)
ES (1) ES2234016T3 (enExample)
GB (1) GB9619002D0 (enExample)
WO (1) WO1998010750A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223739B1 (en) 1995-06-07 2007-05-29 Powderject Vaccines, Inc. Adjuvanted genetic vaccines
US20060002949A1 (en) 1996-11-14 2006-01-05 Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. Transcutaneous immunization without heterologous adjuvant
US5980898A (en) 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US6797276B1 (en) 1996-11-14 2004-09-28 The United States Of America As Represented By The Secretary Of The Army Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
US6884435B1 (en) 1997-01-30 2005-04-26 Chiron Corporation Microparticles with adsorbent surfaces, methods of making same, and uses thereof
ATE235890T1 (de) 1997-01-30 2003-04-15 Chiron Corp Verwendung von mikropartikeln mit adsorbiertem antigen zur stimulierung der immunabwehr
NZ510928A (en) 1998-10-01 2002-10-25 Powderject Res Ltd Spray coated powder composition formed from seed particles between 10-100 micrometres coated with an aqueous pharmaceutical composition
US6881723B1 (en) 1998-11-05 2005-04-19 Powderject Vaccines, Inc. Nucleic acid constructs
PT1146861E (pt) 1999-02-03 2005-10-31 Powderject Res Ltd Formulacoes de particulas de hidrogel
AU3593200A (en) 1999-02-09 2000-08-29 Powderject Vaccines, Inc. (mycobacterium tuberculosis), immunization
US6565528B1 (en) 1999-05-07 2003-05-20 Scimed Life Systems, Inc. Apparatus and method for delivering therapeutic and diagnostic agents
US7147633B2 (en) 1999-06-02 2006-12-12 Boston Scientific Scimed, Inc. Method and apparatus for treatment of atrial fibrillation
US7196066B1 (en) 1999-11-03 2007-03-27 Powderject Vaccines, Inc. DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
JP2004509914A (ja) 2000-09-28 2004-04-02 カイロン コーポレイション 微粒子組成物およびその製造方法
EP1372708B1 (en) 2001-02-13 2008-06-18 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE ARMY Vaccine for transcutaneous immunization against travellers' diarrhoea
GB0103620D0 (en) * 2001-02-14 2001-03-28 Prometic Biosciences Ltd Sterile composition and its preparation
PT1631264E (pt) 2003-06-02 2009-11-03 Novartis Vaccines & Diagnostic Composições imunogénicas à base de micropartículas biodegradáveis que compreendem um toxóide de difteria e do tétano
EP1671655A4 (en) * 2003-08-29 2009-08-12 Anges Mg Inc GENE THERAPY FOR SKIN DISEASE USING NEEDLE-FREE SYRINGE
US9017697B2 (en) 2006-10-12 2015-04-28 The University Of Queensland Compositions and methods for modulating immune responses
DE102007004855B4 (de) * 2007-01-31 2014-03-27 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Vorrichtung und Verfahren zur Deposition von biologischem Material in einem Zielsubstrat
EP2612868B1 (en) 2007-11-01 2018-08-15 Astellas Pharma Inc. Immunosuppressive polypeptides and nucleic acids
CA2816529A1 (en) 2010-11-01 2012-05-10 University Of Technology, Sydney Immune-modulating agents and uses therefor
JP2025523481A (ja) 2022-07-01 2025-07-23 レセンスメディカル、インコーポレイテッド 組成物が冷媒とともにスプレーされることになるモジュール

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994023738A1 (en) * 1993-04-19 1994-10-27 Medisorb Technologies International L.P. Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression
GB9612629D0 (en) * 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery

Also Published As

Publication number Publication date
GB9619002D0 (en) 1996-10-23
EP0928190B1 (en) 2004-11-17
EP0928190A2 (en) 1999-07-14
DE69731646D1 (de) 2004-12-23
DE69731646T2 (de) 2005-12-01
JP2001500858A (ja) 2001-01-23
WO1998010750A3 (en) 1998-06-25
WO1998010750A2 (en) 1998-03-19
ES2234016T3 (es) 2005-06-16

Similar Documents

Publication Publication Date Title
AU4307997A (en) Nucleic acid particle delivery
AU3739697A (en) Gene delivery system
AU3229095A (en) Particle delivery
AU3703895A (en) Particle delivery
AU9692198A (en) Gene delivery compositions and methods
AU7223798A (en) Particle manipulation
AU2023199A (en) Methods, systems, and kits for intravascular nucleic acid delivery
AU2946295A (en) Targeted gene delivery system
AU5743996A (en) Compositions and methods for nucleic acid delivery to the lu ng
GB9605690D0 (en) Particle delivery
AU6982598A (en) Cassette and delivery system
AUPO888097A0 (en) Cross-linked particles
AU6996498A (en) Vehicle handling system
AU9660698A (en) Dna methyltransferase genotyping
AU2816297A (en) Recipient-dosage delivery system
AUPN741696A0 (en) Delivery of nucleic acids ii
AU7706098A (en) Antigen delivery system
AU9792098A (en) Electrostatic particle transportation
AU8374498A (en) Combination counter-ejector shingle-output delivery system
AU6950096A (en) Methods and compositions for nucleic acid targeting
AU5670498A (en) Connector
AU5178999A (en) Nucleic acid delivery
AU7813698A (en) Nucleic acid detection
AU3799397A (en) Ninjurin
AU5345798A (en) Fructan-polycarboxylic acid